Teaser - Drug Reserach Scenario in India (v 0.99)

  • 3,399 views
Uploaded on

The research report of Aagami - ‘Drug Reserach Scenario in India’ – reveals how and what Indian companies are doing in the area of drug research and details out which companies are most active …

The research report of Aagami - ‘Drug Reserach Scenario in India’ – reveals how and what Indian companies are doing in the area of drug research and details out which companies are most active

A must read for global companies who wish to collaborate with Indian companies

More in: Business
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
3,399
On Slideshare
0
From Embeds
0
Number of Embeds
6

Actions

Shares
Downloads
6
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. …………. Realizing PossibilitiesResearch Report on Drug Discovery Scenario in IndiaINTRODUCTIONCommon perception about Indian Pharma companies is that they are good in The research report of Aagami - ‘Drug Scenariogenerics and that drug discovery activities are less in India. in India’ – reveals how and what IndianContrarian to popular belief, it was in the late 1990’s, that Indian Pharma companies are doing in the area of drugcompanies started in-house drug discovery activities, aiming at developing the discovery and details out which companies arecountry’s first home-made drug. most active in the area of drug discovery.Today, there are many Indian companies involved in drug discovery. EvenGovernment is lending help and supporting research activities in a big way through A must read for global companies who wish toIP Protection laws and Public Private Partnerships in this space. collaborate with Indian companiesNew Drug Discovery has gained strong foothold in India.India is today one of the most sought after destinations forcollaboration in drug DiscoveryCopyright © 2012 Aagami, Inc - Research Report/Drug Discovery Scenario in India Page 1
  • 2. …………. Realizing PossibilitiesResearch Scope and Structure Overview: Historical perspective of Trends in Drug Current status in Drug Government Initiatives Conclusion Indain Pharma Market Discovery Discovery  The Indian Pharma  Top Indian Pharma  Major therapeutic  India’s IP regime  Benefits of Collaboration market prior to companies expenditure areas for drug introduction of Patents on R&D. discovery Act of 1970  Presence of  Partnering with MNcs for  Major Platform  Public Private  Conclusion Multinational Drug Discovery /CRO considered/focused for Partnership companies NDDS  Introduction of Patents  M&A  Biosimilars Act of 1970  Impact of TRIPS w.e.f  Paradigm shift  Repurposing January 1995Copyright © 2012 Aagami, Inc - Research Report/Drug Discovery Scenario in India Page 2
  • 3. …………. Realizing PossibilitiesTable of Contents: 1. Introduction a. Objective of white paper b. Executive Summary 2. Acronyms Used 3. Overview: Historical perspective of Indian Pharma market a. Key Takeaway in Indian Pharma sector before and after enactment of Patents Act 1970 b. Table for three phases in Indian Pharmaceuticals. c. Impact of TRIPS on Indian Pharmaceutical companies 4. Scenario in India after 1970 patent Law which recognized process patents a. Example of Importance of India as the “Pharmacy for the developing world 5. Impact of World Trade Organization’s Trade Related Aspects of Intellectual Property Rights (TRIPs) agreement on India 6. Current Status: In-Licensing & Out Licensing Deal (2002- 2011) a. Table for India’s top Pharmaceuticals company by sales and R&D expenditure b. Key examples of Drug discovery collaboration c. Table for R&D Out-Licensing deal. d. Table for Collaborative R&D agreement e. Table for Collaborative research done in India f. Table for Out-Licensing in India with global partners Contract Research (2006-2011) g. Table for R&D service agreement by Indian companies with MNC partner Mergers & Acquisitions (2004- 2012) h. Other R&D deal. i. Matrix for type of Alliances in India 7. Drug Portfolio pipeline of top Indian Pharma companies 8. Examples of Indian companies offering Drug Discovery service 9. Trends in Drug Discovery in India a. Top therapy areas in focus b. Table for Company & therapy areasCopyright © 2012 Aagami, Inc - Research Report/Drug Discovery Scenario in India Page 3
  • 4. …………. Realizing Possibilities c. Biosimilars in India d. Top pharma companies & their biosimilar portfolio e. NDDS f. NDDS success stories & Market segment g. Repurposing of Drugs in India h. Initiatives for Repurposing of Drugs 10. India’s IP regimes & Government Initiatives 11. Benefits Of Collaborations 12. Conclusion Rest of Page is blank. SEE NEXT PAGECopyright © 2012 Aagami, Inc - Research Report/Drug Discovery Scenario in India Page 4
  • 5. …………. Realizing Possibilities Key Highlights of the report: 1. The report gives whole scenario of Drug Discovery activities being carried out in India 2. Current market scenario in India 3. Top Indian Pharma companies with sales and R&D expenditures 4. Information on M&A, Joint research, CRO deals , In-Licensing, Out- Licensing deals took place 5. Top Indian Pharma companies with Drug Portfolios, patent pipeline, NCE pipelines 6. Types of Alliances in India with MNCs. 7. Trends in Drug Discovery 8. Government Initiatives & India IP regime 9. Benefits of Collaborations 10. Facts and figures on India’s advantage for Drug discovery as compared to developed countries A Must Buy for: 1. Foreign companies who wish to collaborate with Indian companies 2. Existing Pharma/Biotech/ Drug Discovery Firms: To know their Indian counterpart Drug Development pipeline, trends, Information on leading pharma companies by sales & their R&D expenses. 3. New Pharma/Biotech/ Drug Discovery Firms: Information on In-Licensing & Out- Licensing scenario. Information on existing & new players in Drug Discovery 4. Research & Educational Institutes: To get an overview of India’s pharma & drug discovery scenario and current trends in Drug R&D 5. Consultants: To upgrade their knowledge in Indian pharma and drug R&D space. 6.Copyright © 2012 Aagami, Inc - Research Report/Drug Discovery Scenario in India Page 5
  • 6. …………. Realizing PossibilitiesSample Snapshots of the Report: The Snapshots provided hereby is just a sneak peak of the whole report. The original document comprise of 34 slides. The report gives a complete scenario about the research activities being carried out in India. India has proven conducive environment, infrastructure to carry out their drug research work and as well assist global pharmaceuticals and biotech firms in their research activities.Copyright © 2012 Aagami, Inc - Research Report/Drug Discovery Scenario in India Page 6
  • 7. …………. Realizing PossibilitiesSample Snapshots of the Report:Copyright © 2012 Aagami, Inc - Research Report/Drug Discovery Scenario in India Page 7
  • 8. …………. Realizing PossibilitiesSample Snapshots of the Report: Contact us at godwyn@aagami.net or Nidhi@aagami.net to have complete access to the full details of the reportCopyright © 2012 Aagami, Inc - Research Report/Drug Discovery Scenario in India Page 8
  • 9. …………. Realizing PossibilitiesSample Snapshots of the Report: Contact us at godwyn@aagami.net or Nidhi@aagami.net to have complete access to the full details of the reportCopyright © 2012 Aagami, Inc - Research Report/Drug Discovery Scenario in India Page 9
  • 10. …………. Realizing Possibilities Contact us at godwyn@aagami.net or Nidhi@aagami.net to have complete access to the full details of the reportCopyright © 2012 Aagami, Inc - Research Report/Drug Discovery Scenario in India Page 10
  • 11. …………. Realizing Possibilities Contact us at godwyn@aagami.net or Nidhi@aagami.net to have complete access to the full details of the reportCopyright © 2012 Aagami, Inc - Research Report/Drug Discovery Scenario in India Page 11
  • 12. …………. Realizing Possibilities Contact us at godwyn@aagami.net or Nidhi@aagami.net to have complete access to the full details of the reportCopyright © 2012 Aagami, Inc - Research Report/Drug Discovery Scenario in India Page 12
  • 13. …………. Realizing Possibilities Contact us at godwyn@aagami.net or Nidhi@aagami.net to have complete access to the full details of the reportCopyright © 2012 Aagami, Inc - Research Report/Drug Discovery Scenario in India Page 13
  • 14. …………. Realizing Possibilities Contact us at godwyn@aagami.net or Nidhi@aagami.net to have complete access to the full details of the reportCopyright © 2012 Aagami, Inc - Research Report/Drug Discovery Scenario in India Page 14
  • 15. …………. Realizing Possibilities Contact us at godwyn@aagami.net or Nidhi@aagami.net to have complete access to the full details of the reportCopyright © 2012 Aagami, Inc - Research Report/Drug Discovery Scenario in India Page 15
  • 16. …………. Realizing Possibilities Contact us at godwyn@aagami.net or Nidhi@aagami.net to have complete access to the full details of the reportCopyright © 2012 Aagami, Inc - Research Report/Drug Discovery Scenario in India Page 16
  • 17. …………. Realizing Possibilities Contact us at godwyn@aagami.net or Nidhi@aagami.net to have complete access to the full details of the reportCopyright © 2012 Aagami, Inc - Research Report/Drug Discovery Scenario in India Page 17
  • 18. …………. Realizing Possibilities Contact us at godwyn@aagami.net or Nidhi@aagami.net to have complete access to the full details of the reportCopyright © 2012 Aagami, Inc - Research Report/Drug Discovery Scenario in India Page 18
  • 19. …………. Realizing Possibilities Contact us at godwyn@aagami.net or Nidhi@aagami.net to have complete access to the full details of the reportCopyright © 2012 Aagami, Inc - Research Report/Drug Discovery Scenario in India Page 19
  • 20. …………. Realizing Possibilities The Snapshots provided in previous pages, is just a sneak peak of the whole report. The original document consists of 34 slides. The report gives a complete scenario about the research activities being carried out in India. India has proven conducive environment, infrastructure to carry out their drug research work and as well assist global pharmaceuticals and biotech firms in their research activities. To place an order for this report, please get in touch with: Godwyn Francis - Head of Business Development, Aagami, Inc. Email Id: godwyn@aagami.net Contact number: +1- 630-780-5830 Aagami Inc, 2020 Calamos Court, Suite 209,Copyright © 2012 Aagami, Inc - Research Report/Drug Discovery Scenario in India Page 20 Naperville IL 60563-2593 www.aagami.net